abstract |
A protein comprising an antibody heavy chain variable domain and an antibody light chain variable domain capable of pairing to form an antigen-binding site that targets FLT3 on a cell, a pharmaceutical composition comprising such a protein, and a treatment of cancer Methods of treatment using such proteins and pharmaceutical compositions are disclosed, including for. |